Product Introduction:
Glycomet Trio 0.3/500/2 mg Tablet is a combination medication containing Metformin, Voglibose, and Glimepiride. It is used to manage type 2 diabetes in adults when diet and exercise alone are insufficient. This medicine works by improving insulin sensitivity, reducing glucose production in the liver, delaying carbohydrate absorption, and increasing insulin secretion.
Uses:
-
Type 2 Diabetes Mellitus
-
Blood sugar level management in diabetic patients
Benefits:
-
Controls both fasting and postprandial blood sugar levels
-
Improves insulin response and sensitivity
-
Prevents diabetes-related complications
-
Reduces glucose absorption in the intestine
Composition:
-
Metformin Hydrochloride 500 mg
-
Glimepiride 2 mg
-
Voglibose 0.3 mg
Side Effects:
-
Hypoglycemia (low blood sugar)
-
Nausea or vomiting
-
Abdominal pain
-
Diarrhea
-
Flatulence
-
Dizziness
Safety Advice:
-
Alcohol: Avoid alcohol as it may increase the risk of lactic acidosis or hypoglycemia.
-
Pregnancy/Breastfeeding: Use only under medical supervision.
-
Kidney/Liver: Not recommended in severe kidney or liver disease.
-
Driving: May cause low blood sugar—avoid driving if affected.
-
Diet: Maintain a proper diabetic diet and exercise plan alongside medication.
-
Monitoring: Regular blood sugar monitoring is advised while on this medication.
